{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:38:30Z","timestamp":1791639510017,"version":"4.3.4"},"reference-count":42,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"DOI":"10.1210\/jc.2014-1532","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T11:49:24Z","timestamp":1405079364000},"page":"E1862-E1869","source":"Crossref","is-referenced-by-count":20,"title":["Short-Term, Low-Dose GH Therapy Improves Insulin Sensitivity Without Modifying Cortisol Metabolism and Ectopic Fat Accumulation in Adults With GH Deficiency"],"prefix":"10.1210","volume":"99","author":[{"given":"Kevin C. J.","family":"Yuen","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., C.T.R., B.J.K., J.Q.P.), Portland, Oregon 97239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles T.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., C.T.R., B.J.K., J.Q.P.), Portland, Oregon 97239"},{"name":"Oregon National Primate Research Center (C.T.R.), Beaverton, Oregon 97006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine N (J.F.), Aarhus University, DK-8000 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Rooney","sequence":"additional","affiliation":[{"name":"Department of Medicine, and Advanced Imaging Research Center (W.D.R., J.R.P.), Oregon Health and Science University, Portland, Oregon 97239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Pollaro","sequence":"additional","affiliation":[{"name":"Department of Medicine, and Advanced Imaging Research Center (W.D.R., J.R.P.), Oregon Health and Science University, Portland, Oregon 97239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany J.","family":"Klopfenstein","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., C.T.R., B.J.K., J.Q.P.), Portland, Oregon 97239"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Q.","family":"Purnell","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Clinical Nutrition (K.C.J.Y., C.T.R., B.J.K., J.Q.P.), Portland, Oregon 97239"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"3","key":"2019041116122421400_B1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041116122421400_B2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1210\/jc.2007-2371","article-title":"Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study","volume":"93","author":"Beauregard","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041116122421400_B3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.metabol.2009.08.002","article-title":"Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement","volume":"59","author":"Roemmler","year":"2010","journal-title":"Metabolism"},{"issue":"9","key":"2019041116122421400_B4","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/jc.2007-2810","article-title":"Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency","volume":"93","author":"Colao","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041116122421400_B5","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.orcp.2011.09.001","article-title":"Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus","volume":"6","author":"Sato","year":"2012","journal-title":"Obes Res Clin Pract"},{"issue":"4","key":"2019041116122421400_B6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle","volume":"88","author":"Bramnert","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041116122421400_B7","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041116122421400_B8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2265.2002.01601.x","article-title":"The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults","volume":"57","author":"Yuen","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019041116122421400_B9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02359.x","article-title":"Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency","volume":"63","author":"Yuen","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2019041116122421400_B10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00125-010-1738-4","article-title":"Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study","volume":"53","author":"Arafat","year":"2010","journal-title":"Diabetologia"},{"key":"2019041116122421400_B11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000314272","article-title":"Metabolic syndrome in Cushing's syndrome","volume":"92","author":"Chanson","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2019041116122421400_B12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11154-010-9142-4","article-title":"Is metabolic syndrome a mild form of Cushing's syndrome?","volume":"11","author":"Krikorian","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"2019041116122421400_B13","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1210\/jc.2004-1114","article-title":"Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients","volume":"89","author":"Giavoli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041116122421400_B14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2005-1694","article-title":"Growth hormone (GH) substitution in GH-deficient patients inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue","volume":"91","author":"Paulsen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041116122421400_B15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"issue":"2","key":"2019041116122421400_B16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1998.3641180.x","article-title":"The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11\u03b2-hydroxysteroid dehydrogenase activity","volume":"48","author":"Gelding","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2019041116122421400_B17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11892-008-0032-z","article-title":"Ectopic fat and insulin resistance","volume":"8","author":"Lettner","year":"2008","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2019041116122421400_B18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.2003.036566","article-title":"Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study","volume":"54","author":"Thomas","year":"2005","journal-title":"Gut"},{"issue":"6","key":"2019041116122421400_B19","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1152\/jappl.1999.87.6.2068","article-title":"Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS","volume":"87","author":"Rico-Sanz","year":"1999","journal-title":"J Appl Physiol (1985)"},{"issue":"36","key":"2019041116122421400_B20","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\u20136","key":"2019041116122421400_B21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clinbiochem.2010.12.008","article-title":"Determination of cortisol production rates with contemporary liquid chromatography-mass spectrometry to measure cortisol-d(3) dilution after infusion of deuterated tracer","volume":"44","author":"Klopfenstein","year":"2011","journal-title":"Clin Biochem"},{"issue":"1018","key":"2019041116122421400_B22","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1259\/bjr\/57987644","article-title":"Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans","volume":"85","author":"Klopfenstein","year":"2012","journal-title":"Br J Radiol"},{"issue":"5 Pt 1","key":"2019041116122421400_B23","first-page":"E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am J Physiol"},{"issue":"9","key":"2019041116122421400_B24","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00125-005-1850-z","article-title":"Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications","volume":"48","author":"Frystyk","year":"2005","journal-title":"Diabetologia"},{"issue":"5","key":"2019041116122421400_B25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1210\/jc.2006-2310","article-title":"Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children","volume":"92","author":"Andersen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116122421400_B26","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-3060","article-title":"Age and sex specific reference intervals across life-span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I\/IGFBP-3 ratio measured by new automated chemiluminescence assays","author":"Friedrich","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041116122421400_B27","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2019041116122421400_B28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.domaniend.2011.11.005","article-title":"Quantification of the GH\/IGF-axis components: lessons from human studies","volume":"43","author":"Frystyk","year":"2012","journal-title":"Domest Anim Endocrinol"},{"issue":"4","key":"2019041116122421400_B29","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul"},{"issue":"1","key":"2019041116122421400_B30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2369-14-80","article-title":"Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study","volume":"14","author":"Reinhard","year":"2013","journal-title":"BMC Nephrol"},{"issue":"8","key":"2019041116122421400_B31","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2011-0273","article-title":"Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults","volume":"96","author":"Krusenstjerna-Hafstrom","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041116122421400_B32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2006.02507.x","article-title":"Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency","volume":"64","author":"Yuen","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019041116122421400_B33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2004.00126.x","article-title":"Hepatic steatosis in obese patients: clinical aspects and prognostic significance","volume":"5","author":"Festi","year":"2004","journal-title":"Obes Rev"},{"issue":"31","key":"2019041116122421400_B34","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"2019041116122421400_B35","first-page":"6","article-title":"Individual IGF-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency","volume":"65","author":"Yuen","year":"2006","journal-title":"Horm Res"},{"issue":"5","key":"2019041116122421400_B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ghir.2004.06.001","article-title":"Free insulin-like growth factors\u2014measurements and relationships to growth hormone secretion and glucose homeostasis","volume":"14","author":"Frystyk","year":"2004","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"2019041116122421400_B37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2019041116122421400_B38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"issue":"3","key":"2019041116122421400_B39","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041116122421400_B40","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1152\/ajpendo.90769.2008","article-title":"Enhanced cortisol production rates, free cortisol, and 11\u03b2-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss","volume":"296","author":"Purnell","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2019041116122421400_B41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2013.08.077","article-title":"Ectopic fat and cardiometabolic and vascular risk","volume":"169","author":"Lim","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"2019041116122421400_B42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med (Berl)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/10\/E1862\/9108038\/jcem1862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:42:45Z","timestamp":1555033365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/10\/E1862\/2836154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-1532","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}